Longitudinal Survey Analysis in Lymphoma Survivors

NCT01469754 | Completed

• 1 other identifier: 1107011786
• Study Type: observational
• Target: 97
• Locations: 1 country
• Sites: 1

Brief Summary

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD. Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth. Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Conditions

Lymphoma; Posttraumatic Stress Disorder; Posttraumatic Growth; Coping; Resilience

Keywords

lymphoma; survivors; posttraumatic growth; posttraumatic stress; longitudinal

Outcome Measures

Primary Outcomes (1)

• Posttraumatic Growth

  Measured at enrollment

Secondary Outcomes (1)

• Posttraumatic Stress Disorder (PTSD)

  Measured at Enrollment

Study Arms (1)

Lymphoma Survivors

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Lymphoma survivors who have completed initial treatment within the last 3 months

You may qualify if:

• Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)
• Can read/write/understand English without a translator

You may not qualify if:

• Currently Hospitalized
• Active Psychosis

Sponsors & Collaborators

• Weill Medical College of Cornell University: lead

Study Sites (1)

New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma

New York, New York, 10065, United States

Location

Related Links

• WCMC Link to Study Description

MeSH Terms

Conditions

Lymphoma; Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases; Stress Disorders, Traumatic; Trauma and Stressor Related Disorders; Mental Disorders

Study Officials

• Regina A Jacob, MD

  WCMC Research Fellow

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 8, 2011
• First Posted: November 10, 2011
• Study Start: September 1, 2011
• Primary Completion: July 1, 2013
• Study Completion: September 1, 2013
• Last Updated: May 5, 2014

Record last verified: 2014-05

Locations

US (1)